Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,270.19
-7.32(-0.14%)
Dow
38,442.79
-243.53(-0.63%)
Nasdaq
16,794.94
+59.92(+0.36%)
Bitcoin USD
69,197.44
+1,159.06(+1.70%)
CMC Crypto 200
1,487.56
+19.62(+1.34%)

BMY Jan 2025 25.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.1800

+0.0100

(+5.88%)

As of 10:28AM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....